,
3 Protocole d'acquisition d'une TEP à la 18F-FDOPA ,
6 Sécrétion de catécholamines et intensité de captation de la 18F-FDOPA : une corrélation ? ,
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.6, pp.1915-1942, 2014. ,
THERAPY OF ENDOCRINE DISEASE: Treatment of malignant pheochromocytoma and paraganglioma, European Journal of Endocrinology, vol.171, issue.3, pp.R111-R122, 2014. ,
,
Pheochromocytoma and paraganglioma, Current Opinion in Oncology, vol.28, issue.1, pp.5-10, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01048691
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine, Nature Reviews Endocrinology, vol.11, issue.2, pp.101-111, 2014. ,
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas, Cancer Research, vol.63, pp.5615-5621, 2003. ,
Is the Excess Cardiovascular Morbidity in Pheochromocytoma Related to Blood Pressure or to Catecholamines?, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.3, pp.1100-1106, 2013. ,
Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol-O-Methyltransferase Within Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.83, issue.6, pp.2175-2185, 1998. ,
Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in theSuccinate Dehydrogenase Subunit BGene, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.12, pp.4826-4832, 2008. ,
Chromogranin A assay in clinical practice, Annales d'Endocrinologie, vol.71, pp.274-280, 2010. ,
The optimal imaging of adrenal tumours: a comparison of different methods, Endocrine Related Cancer, vol.14, issue.3, pp.587-599, 2007. ,
Imaging Work-Up for Screening of Paraganglioma and Pheochromocytoma inSDHxMutation Carriers: A Multicenter Prospective Study from the PGL.EVA Investigators, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.1, pp.E162-E173, 2013. ,
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma, European Journal of Nuclear Medicine and Molecular Imaging, vol.39, issue.12, pp.1977-1995, 2012. ,
15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma, Endocrine-Related Cancer, vol.22, issue.4, pp.T135-T145, 2015. ,
Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms, The American Journal of Surgical Pathology, vol.26, issue.5, pp.551-566, 2002. ,
Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin, The Netherlands Journal of Medicine, 0201. ,
MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma, European Journal of Endocrinology, vol.174, issue.1, pp.R9-R18, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01473972
Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.11, pp.4040-4050, 2012. ,
Principe et technique de la tomographie par émission de positons (TEP), 200412. ,
6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications, Journal of Nuclear Medicine, vol.49, issue.4, pp.573-586, 2008. ,
Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer, Nuclear Medicine Communications, vol.33, issue.7, pp.775-779, 2012. ,
The Effects of Carbidopa on Uptake of 6-18F-Fluoro-L-DOPA in PET of Pheochromocytoma and Extraadrenal Abdominal Paraganglioma, Journal of Nuclear Medicine, vol.48, issue.10, pp.1599-1606, 2007. ,
Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging, Nuclear Medicine Communications, vol.34, issue.12, pp.1141-1149, 2013. ,
Anatomy of SUV, Nuclear Medicine and Biology, vol.27, issue.7, pp.643-646, 2000. ,
Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET, Nuclear Medicine Communications, vol.29, issue.6, pp.521-526, 2008. ,
Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis, European Journal of Nuclear Medicine and Molecular Imaging, vol.2012, pp.39-1144 ,
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas, Clinical Endocrinology, pp.69-580, 2008. ,
Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: Results of a prospective case-control study, Surgery, vol.150, issue.6, pp.1202-1211, 2011. ,
Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective casecontrol study, Surgery, vol.150, pp.1202-1211, 2011. ,
, An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 1915.
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine, Nature Reviews Endocrinology, vol.11, issue.2, pp.101-111, 2014. ,
guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma, European Journal of Nuclear Medicine and Molecular Imaging, 1977. ,
15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma, Endocrine-Related Cancer, vol.22, issue.4, pp.T135-T145, 2015. ,
6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications, Journal of Nuclear Medicine, vol.49, issue.4, pp.573-586, 2008. ,
, Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications, pp.49-573, 2008.
Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, issue.2, pp.278-282, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01876274
Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype, European Journal of Nuclear Medicine and Molecular Imaging, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01876274
Analysis of exocytotic events recorded by amperometry, Nature Methods, vol.2, issue.9, pp.651-658, 2005. ,
Pheochromocytoma Catecholamine Phenotypes and Prediction of Tumor Size and Location by Use of Plasma Free Metanephrines, Clinical Chemistry, vol.51, issue.4, pp.735-744, 2005. ,
Pheochromocytoma Catecholamine Phenotypes and Prediction of Tumor Size and Location by Use of Plasma Free Metanephrines, Clinical Chemistry, pp.51-735, 2005. ,
Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to ,
Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms, The American Journal of Surgical Pathology, vol.26, issue.5, pp.551-566, 2002. ,
Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET, Nuclear Medicine Communications, vol.29, issue.6, pp.521-526, 2008. ,
Oligophrenin-1 Connects Exocytotic Fusion to Compensatory Endocytosis in Neuroendocrine Cells, Journal of Neuroscience, vol.35, issue.31, pp.11045-11055, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02323341
Oligophrenin-1 Connects Exocytotic Fusion to Compensatory Endocytosis in Neuroendocrine Cells, The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol.35, pp.11045-11055, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02323341
Automatic analysis for amperometrical recordings of exocytosis, Journal of Neuroscience Methods, vol.103, issue.2, pp.151-156, 2000. ,
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management, Endocrine Reviews, vol.25, issue.2, pp.309-340, 2004. ,
The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas, Endocrine, vol.59, issue.3, pp.529-537, 2018. ,
6-[F-18]Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.10, pp.3922-3930, 2009. ,
Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess, The Journal of Clinical Endocrinology & Metabolism, vol.94, pp.3922-3930, 2009. ,
18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas, Journal of Nuclear Medicine, vol.50, issue.4, pp.513-519, 2009. ,
Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study, Journal of Nuclear Medicine, vol.45, pp.1519-1527, 2004. ,
SUV: standard uptake or silly useless value, Journal of Nuclear Medicine, vol.36, pp.1836-1839, 1995. ,
Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study, The Journal of Clinical Endocrinology & Metabolism, vol.102, issue.7, pp.2465-2472, 2017. ,
,
Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study, The Journal of Clinical Endocrinology & Metabolism, vol.102, pp.2465-2472, 2017. ,
18F-Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Adrenocortical Tumors: A Prospective Study in 77 Operated Patients, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.5, pp.1713-1722, 2009. ,
Positron Emission Tomography for the Diagnosis of Adrenocortical Tumors: A Prospective Study in 77 Operated Patients, The Journal of Clinical Endocrinology & Metabolism, vol.94, pp.1713-1722, 2009. ,
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors, The American Journal of Surgical Pathology, vol.8, issue.3, pp.163-170, 1984. ,
Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma, Journal of Nuclear Medicine, vol.53, issue.12, pp.1863-1871, 2012. ,
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour, European Journal of Nuclear Medicine and Molecular Imaging, vol.38, issue.10, pp.1854-1861, 2011. ,
Normotensive Incidentally Discovered Pheochromocytomas Display Specific Biochemical, Cellular, and Molecular Characteristics, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.11, pp.4346-4354, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01706417
Normotensive Incidentally Discovered Pheochromocytomas Display Specific Biochemical, Cellular, and Molecular Characteristics, The Journal of Clinical Endocrinology & Metabolism, pp.98-4346, 2013. ,
Life-threatening events in patients with pheochromocytoma, European Journal of Endocrinology, vol.173, issue.6, pp.757-764, 2015. ,
Life-threatening events in patients with pheochromocytoma, European Journal of Endocrinology, pp.173-757, 2015. ,
Pheochromocytoma: presentation, diagnosis and treatment, Journal of Hypertension, 2331. ,
Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype, European Journal of Nuclear Medicine and Molecular Imaging, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01876274
18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas, Journal of Nuclear Medicine, vol.50, issue.4, pp.513-519, 2009. ,
6-[F-18]Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.10, pp.3922-3930, 2009. ,
Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess, The Journal of Clinical Endocrinology & Metabolism, vol.94, pp.3922-3930, 2009. ,
Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study, Journal of Nuclear Medicine, vol.45, pp.1519-1527, 2004. ,
The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas, Endocrine, vol.59, issue.3, pp.529-537, 2018. ,
Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study, The Journal of Clinical Endocrinology & Metabolism, vol.102, issue.7, pp.2465-2472, 2017. ,
18F-Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Adrenocortical Tumors: A Prospective Study in 77 Operated Patients, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.5, pp.1713-1722, 2009. ,
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors, The American Journal of Surgical Pathology, vol.8, issue.3, pp.163-170, 1984. ,
Correlation of 6-18F-Fluoro-l-Dopa PET Uptake with Proliferation and Tumor Grade in Newly Diagnosed and Recurrent Gliomas, Journal of Nuclear Medicine, vol.51, pp.1532-1538, 2010. ,
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour, European Journal of Nuclear Medicine and Molecular Imaging, vol.38, issue.10, pp.1854-1861, 2011. ,
Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma, Journal of Nuclear Medicine, vol.53, issue.12, pp.1863-1871, 2012. ,
Normotensive Incidentally Discovered Pheochromocytomas Display Specific Biochemical, Cellular, and Molecular Characteristics, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.11, pp.4346-4354, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01706417
Analysis of exocytotic events recorded by amperometry, Nature Methods, vol.2, issue.9, pp.651-658, 2005. ,
15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma, Endocrine-Related Cancer, vol.22, issue.4, pp.T135-T145, 2015. ,
Carte des Îles de Pong-hou suivant le point sur le quel ont été faites les Cartes de la Chine et de la Tartarie par l'Ordre et aux frais de l'Empereur, * aux*taux*de*NM*urinaires*(r=0.64,*p<0.0001,*n=36)*et*de*MN*urinaires*(r=0.49,*p=0.002,*n=35)*ainsi* qu'aux*taux*de*NM*plasmatiques*(r=0.55*p=0.006,*n=23)*et*de*CGA*(r=0.61,*p=0.0005,*n=28).*Les* paramètres*SUVs*(SUVmoyen,*SUVmax)*sont*quant*à*eux*uniquement*corrélés*avec*la*CGA* ,
* pics* par* cellule* obtenu* pour* chaque* tumeur* (r=1,* p=0,01).** Conclusion& :* Le* MB* est* un* outil* important* pour* la* détermination* de* la* sécrétion* hormonale* des* phéochromocytomes*en*TEP/TDM.*L'augmentation*de*l'activité*de*l'exocytose*au*niveau*cellulaire* semble*favoriser*la*captation*de* 18 F^FDOPA.* & TITRE&EN&ANGLAIS&:&DOES* 18, 2018. ,
,
,